• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

黄芪甲苷通过抑制 TGF-β1/Smad3 信号通路抑制二氧化硅诱导的肺纤维化。

Inhibitory effects of astragaloside IV on silica-induced pulmonary fibrosis via inactivating TGF-β1/Smad3 signaling.

机构信息

Department of Respiratory Medicine, The Second Hospital of Shandong University, Jinan, 250033, Shandong, PR China; Department of Respiratory Medicine, Central Hospital of Tai'an of Shandong Province, Tai'an, 271000, Shandong, PR China.

Department of Respiratory Medicine, The Second Hospital of Shandong University, Jinan, 250033, Shandong, PR China.

出版信息

Biomed Pharmacother. 2019 Nov;119:109387. doi: 10.1016/j.biopha.2019.109387. Epub 2019 Sep 2.

DOI:10.1016/j.biopha.2019.109387
PMID:31487583
Abstract

PURPOSE

To observe the effect of astragaloside ASV (ASV) on silicosis fibroblasts, and further investigate its regulatory mechanism on TGF-β1/Smad3 signaling pathway.

METHODS

Silica-induced rats model was established in this study. RT-qPCR was performed to detect α-SMA, Collagen I, Collagen III, Smad2, Smad3 and Smad7 expression. Immunofluorescence was conducted to detect α-SMA, Collagen I, Collagen III and p-Smad3 protein and the nucleoplasmic distribution of p-Smad3.Western-blotting was performed to detect the protein of Smad2, p-Smad2, Smad3, p-Smad3 and Smad7.

RESULTS

20 μg/mL ASV could effectively reduce the expression of α-SMA, Collagen I, Collagen III. TGF-β1 stimulated the proliferation of fibroblasts, promoted phosphorylation of Smad2 and Smad3, and down-regulated Smad7 expression. Among them, continuous phosphorylation of Smad3 is a major factor in causing fibrosis. Besides, ASV can inhibit silica-induced lung fibroblast fibrosis through TGF-β1/Smad3 signaling pathway, thereby inhibiting the formation of silicosis.

CONCLUSION

ASV could inhibit the expression of collagen in fibroblasts and the transformation to myofibroblasts, and has an anti-silicosis fibrosis effect, which may be related to the continuous phosphorylation of Smad3 in the TGF-β1/Smad signaling pathway.

摘要

目的

观察黄芪甲苷(ASV)对矽肺成纤维细胞的作用,进一步探讨其对 TGF-β1/Smad3 信号通路的调控机制。

方法

本研究建立了矽肺大鼠模型。采用 RT-qPCR 检测 α-SMA、Collagen I、Collagen III、Smad2、Smad3 和 Smad7 的表达。免疫荧光法检测 α-SMA、Collagen I、Collagen III 和 p-Smad3 蛋白及 p-Smad3 的核质分布。Western-blotting 检测 Smad2、p-Smad2、Smad3、p-Smad3 和 Smad7 的蛋白表达。

结果

20μg/mL ASV 可有效降低 α-SMA、Collagen I、Collagen III 的表达。TGF-β1 刺激成纤维细胞增殖,促进 Smad2 和 Smad3 磷酸化,下调 Smad7 表达。其中,Smad3 的持续磷酸化是导致纤维化的主要因素。此外,ASV 可通过 TGF-β1/Smad3 信号通路抑制矽肺肺成纤维细胞纤维化,从而抑制矽肺的形成。

结论

ASV 可抑制成纤维细胞中胶原的表达和向肌成纤维细胞的转化,具有抗矽肺纤维化作用,可能与 TGF-β1/Smad 信号通路中 Smad3 的持续磷酸化有关。

相似文献

1
Inhibitory effects of astragaloside IV on silica-induced pulmonary fibrosis via inactivating TGF-β1/Smad3 signaling.黄芪甲苷通过抑制 TGF-β1/Smad3 信号通路抑制二氧化硅诱导的肺纤维化。
Biomed Pharmacother. 2019 Nov;119:109387. doi: 10.1016/j.biopha.2019.109387. Epub 2019 Sep 2.
2
Astragaloside IV alleviates silica‑induced pulmonary fibrosis via inactivation of the TGF‑β1/Smad2/3 signaling pathway.黄芪甲苷通过抑制 TGF-β1/Smad2/3 信号通路缓解二氧化硅诱导的肺纤维化。
Int J Mol Med. 2021 Mar;47(3). doi: 10.3892/ijmm.2021.4849. Epub 2021 Jan 15.
3
Tanshinone IIA attenuates silica-induced pulmonary fibrosis via inhibition of TGF-β1-Smad signaling pathway.丹参酮 IIA 通过抑制 TGF-β1-Smad 信号通路减轻二氧化硅诱导的肺纤维化。
Biomed Pharmacother. 2020 Jan;121:109586. doi: 10.1016/j.biopha.2019.109586. Epub 2019 Nov 6.
4
Synergistic anti-liver fibrosis actions of total astragalus saponins and glycyrrhizic acid via TGF-β1/Smads signaling pathway modulation.黄芪总皂苷与甘草酸通过调节TGF-β1/Smads信号通路协同发挥抗肝纤维化作用。
J Ethnopharmacol. 2016 Aug 22;190:83-90. doi: 10.1016/j.jep.2016.06.011. Epub 2016 Jun 6.
5
Cannabidiol suppresses silica-induced pulmonary inflammation and fibrosis through regulating NLRP3/TGF-β1/Smad2/3 pathway.大麻二酚通过调节 NLRP3/TGF-β1/Smad2/3 通路抑制二氧化硅诱导的肺炎症和纤维化。
Int Immunopharmacol. 2024 Dec 5;142(Pt A):113088. doi: 10.1016/j.intimp.2024.113088. Epub 2024 Sep 7.
6
[Tofacitinib inhibits the transformation of lung fibroblasts into myofibroblasts through JAK/STAT3 pathway].托法替布通过JAK/STAT3信号通路抑制肺成纤维细胞向肌成纤维细胞的转化。
Beijing Da Xue Xue Bao Yi Xue Ban. 2024 Jun 18;56(3):505-511. doi: 10.19723/j.issn.1671-167X.2024.03.018.
7
The inhibitory effect of ginsan on TGF-β mediated fibrotic process. Ginsan 对 TGF-β 介导的纤维化过程的抑制作用。
J Cell Physiol. 2011 May;226(5):1241-7. doi: 10.1002/jcp.22452.
8
Simvastatin inhibits transforming growth factor-β1-induced expression of type I collagen, CTGF, and α-SMA in keloid fibroblasts.辛伐他汀抑制瘢痕成纤维细胞中转化生长因子-β1 诱导的 I 型胶原、结缔组织生长因子和 α-SMA 的表达。
Wound Repair Regen. 2014 Jan-Feb;22(1):125-33. doi: 10.1111/wrr.12136. Epub 2013 Dec 13.
9
Smad2 and Smad3 as mediators of the response of adventitial fibroblasts induced by transforming growth factor β1.Smad2 和 Smad3 作为转化生长因子 β1 诱导的外膜成纤维细胞反应的介质。
Mol Med Rep. 2011 May-Jun;4(3):561-7. doi: 10.3892/mmr.2011.458. Epub 2011 Mar 18.
10
USP7 Promotes TGF-β1 Signaling by De-Ubiquitinating Smad2/Smad3 in Pulmonary Fibrosis.USP7 通过去泛素化 Smad2/Smad3 促进肺纤维化中的 TGF-β1 信号传导。
Discov Med. 2024 Aug;36(187):1616-1626. doi: 10.24976/Discov.Med.202436187.148.

引用本文的文献

1
A comprehensive review on the cellular mechanism of traditional Chinese medicine in the treatment of pediatric lung diseases.中医药治疗小儿肺部疾病细胞机制的综合综述
Bioimpacts. 2025 Apr 6;15:30945. doi: 10.34172/bi.30945. eCollection 2025.
2
Astragaloside IV combined with quercetin attenuates silica-induced pulmonary fibrosis by promoting autophagy and suppressing pyroptosis.黄芪甲苷联合槲皮素通过促进自噬和抑制细胞焦亡减轻二氧化硅诱导的肺纤维化。
PLoS One. 2025 Jun 25;20(6):e0327255. doi: 10.1371/journal.pone.0327255. eCollection 2025.
3
Nebulized milk exosomes loaded with siTGF-β1 ameliorate pulmonary fibrosis by inhibiting EMT pathway and enhancing collagen permeability.
雾化载有 siTGF-β1 的牛奶外泌体通过抑制 EMT 通路和增强胶原通透性来改善肺纤维化。
J Nanobiotechnology. 2024 Jul 23;22(1):434. doi: 10.1186/s12951-024-02721-z.
4
Pulmonary Rehabilitation Strategies for the Treatment of Pneumoconiosis: A Narrative Review.尘肺病治疗的肺康复策略:一篇叙述性综述
Iran J Public Health. 2023 Nov;52(11):2234-2247. doi: 10.18502/ijph.v52i11.14024.
5
Research progress on the mechanism of astragaloside IV in the treatment of asthma.黄芪甲苷治疗哮喘作用机制的研究进展
Heliyon. 2023 Nov 10;9(11):e22149. doi: 10.1016/j.heliyon.2023.e22149. eCollection 2023 Nov.
6
Animal models of silicosis: fishing for new therapeutic targets and treatments.矽肺的动物模型:寻找新的治疗靶点和治疗方法。
Eur Respir Rev. 2023 Aug 9;32(169). doi: 10.1183/16000617.0078-2023. Print 2023 Sep 30.
7
A systematic review of the research progress of traditional Chinese medicine against pulmonary fibrosis: from a pharmacological perspective.从药理学角度对中医药抗肺纤维化研究进展的系统综述
Chin Med. 2023 Aug 3;18(1):96. doi: 10.1186/s13020-023-00797-7.
8
Astragaloside IV ameliorates peritoneal fibrosis by promoting PGC-1α to reduce apoptosis in vitro and in vivo.黄芪甲苷通过促进 PGC-1α 减少细胞凋亡来改善腹膜纤维化,无论是在体外还是体内研究中。
J Cell Mol Med. 2023 Oct;27(19):2945-2955. doi: 10.1111/jcmm.17871. Epub 2023 Jul 26.
9
Astragaloside IV alleviates lung inflammation in Klebsiella pneumonia rats by suppressing TGF-β1/Smad pathway.黄芪甲苷通过抑制 TGF-β1/Smad 通路减轻肺炎克雷伯菌大鼠肺部炎症。
Braz J Med Biol Res. 2023 Jul 21;56:e12203. doi: 10.1590/1414-431X2023e12203. eCollection 2023.
10
Untapping the Potential of Astragaloside IV in the Battle Against Respiratory Diseases.黄芪甲苷在防治呼吸系统疾病中的潜力挖掘。
Drug Des Devel Ther. 2023 Jul 3;17:1963-1978. doi: 10.2147/DDDT.S416091. eCollection 2023.